In bone cells, BSE down-regulate RANKL, inhibiting osteoclastogenesis [79], and reduce the expression of vascular endothelial growth factor (VEGF), which is involved in pathological angiogenesis, that could help to reduce subchondral bone damage during osteoarthritis [81]. This evidence concerns the gene VEGFA and osteoarthritis.